FY2029 Earnings Forecast for ABOS Issued By HC Wainwright

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS – Free Report) – HC Wainwright issued their FY2029 earnings estimates for shares of Acumen Pharmaceuticals in a research note issued on Friday, March 28th. HC Wainwright analyst A. Fein anticipates that the company will post earnings of ($2.03) per share for the year. HC Wainwright currently has a “Buy” rating […]

Leave a Reply

Your email address will not be published.

Previous post SigmaTron International (NASDAQ:SGMA) Now Covered by Analysts at StockNews.com
Next post Thrivent Financial for Lutherans Boosts Stock Position in Park Hotels & Resorts Inc. (NYSE:PK)